Books in the Wiley Series on Technologies for the Pharmaceutical Industry series

Placing an emphasis on industry issues, Pharmaceutical Applications of Raman Spectroscopy provides the basic theory of Raman effect and instrumentation, and then addresses a wide range of pharmaceutical applications. Current applications that are routinely used as well as those with promising potential are covered.

This book introduces drug researchers to the novel computational approaches of pathway analysis and explains the existing applications that can save time and money in the drug discovery process. It covers traditional computational methods and software for pathway analysis microarray, proteomics, and metabolomics.

This book covers key emerging technologies - detailed under About the Topic - in pharmaceutical R & D and how they have substantially impacted (or are currently impacting) drug discovery. The cross-disciplinary collaborations implicit in integrating these technologies with drug discovery operations will fuel the engine for future innovations.

Explains the rise of information based medicine and how it can improve the cost and practice of pharmaceutical and medical science Covers a broad range of topics - history, philosophy, economy, mathematics, computers, etc.

This book explores many critical forces at work today in pharmaceutical and medical product development. Applying a structured project management framework enables companies to select and allocate the appropriate people and resources to achieve success.

Extracting and applying knowledge from chemical, biological, and clinical data is one of the biggest problems for the pharmaceutical industry.

This is the first comprehensive systems biology book to focus on its applications in drug discovery and development. It covers all phases of drug discovery and development, discussing their interaction with systems biology. Using real-world examples, the book shows how systems biology can enhance pharmaceutical research.

Covering a neglected but important topic of management and information technology collaborations in drug discovery and development, this book discusses the state-of-the-art collaborative and computing techniques for the pharmaceutical industry.

Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers.

Reflecting the changing drug discovery landscape, Collaborative Drug Discovery offers an alternative model for the pharma industry. Here, readers discover how to pursue new avenues of drug discovery with academic partners focused on discovery research and industry on later-stage development.

Dieses Buch ist ein wichtiges Referenzwerk für Toxikologen in vielen Bereichen und bietet eine umfassende Analyse molekular Modellansätze und Strategien der Risikobewertung von pharmazeutischen und Umweltchemikalien.- Zeigt, was mit rechnergestützter Toxikologie aktuell erreicht werden kann, und wirft einen Blick auf zukünftige Entwicklungen.- Gibt Antworten zu Themen wie Datenquellen, Datenpflege, Behandlung, Modellierung und Interpretation kritischer Endpunkte im Hinblick auf Gefahrenbewertungen im 21. Jahrhundert.- Bündelt herausragende Konzepte und das Wissen führender Autoren in einem einzigartigen Referenzwerk.- Untersucht detailliert QSAR-Modelle, Eigenschaften physiochemischer Arzneistoffe, strukturbasiertes Drug Targeting, die Bewertung chemischer Mischungen und Umweltmodelle.- Behandelt zusätzlich die Sicherheitsbewertung von Verbraucherprodukten und den Bereich chemische Abwehr und bietet Kapitel zu Open-Source-Toxikologie und Big Data.